共查询到19条相似文献,搜索用时 156 毫秒
1.
2.
3.
细胞的抗原表位研究方法 总被引:3,自引:0,他引:3
多表位疫苗有望成为预防多种病原体感染的理想疫苗,因而被认为是将来疫苗的发展方向。抗原表位是研究抗原的免疫机制和表位疫苗的基础,近年来在表位研究方面取得了一些可喜的进展,特别是抗原表位的研究方法。B细胞表位的研究方法已经不局限于通过交叠合成多肽进行研究,又诞生了噬菌体随机肽库以及表位预测等方法;在T细胞抗原表位的研究方面也有了相应的预测方法,尤其是将ELISPOT试验、体外抗原提呈试验等应用于T细胞表位活性的鉴定,极大的促进了T细胞表位的研究进展。文章全面系统地对B细胞表位与T细胞表位的研究方法的进展进行了综述。旨在为表位和表位疫苗的研究提供先进的多种技术方法。 相似文献
4.
应用生物信息学方法预测H6亚型禽流感病毒血凝素蛋白(HA)线性抗原表位,并对所获表位的免疫原性进行初步鉴定,为流感病毒表位疫苗研制和H6亚型特异性ELISA检测方法奠定基础。依据近年流感病毒流行趋势,从GenBank下载具有代表性的H6、H5、H7和H9亚型禽流感病毒血凝素蛋白的氨基酸序列。利用DNA Star软件进行H6同亚型间氨基酸序列保守性分析,再将H6与H5、H7、H9不同亚型之间氨基酸同源性进行比较,然后借助在线服务器ExPASy和IEDB对序列进行抗原性、亲水性、柔韧性、二级结构和表面可及性预测。最后去除H6与H5、H7、H9亚型氨基酸同源区域,选择H6亚型氨基酸相对保守区域并且抗原表位综合预测结果较优的几个片段,所选择表位长度为15个氨基酸。合成所获得的优势线性表位,并用间接ELISA方法对所获表位的免疫原性进行鉴定。预测后获得4个线性抗原表位,经鉴定免疫原性最好的为表位A,最差的为表位B。 相似文献
5.
病毒多表位疫苗是利用免疫学和基因工程技术筛选出病毒的抗原表位,同时结合计算机技术对表位进行优化,将同一病毒的不同细胞表位或者不同亚型病毒的细胞表位串联表达而制成的新型疫苗。由于病毒多表位疫苗在安全性、稳定性以及免疫效力等诸多方面的优势,已成为当前病毒疫苗研究的热点。本文从病毒抗原表位的确定方法、不同表位疫苗以及病毒多表位疫苗的免疫途径和安全性等几方面对病毒多表位疫苗作一综述。 相似文献
6.
7.
8.
H1N1猪流感病毒血凝素蛋白抗原表位的筛选及其抗原性分析 总被引:1,自引:1,他引:0
本研究旨在对H1N1猪流感病毒血凝素蛋白抗原分子的模拟表位进行分离鉴定并分析其抗原性。用抗H1N1猪流感病毒血凝素蛋白小鼠血清IgG对噬菌体随机12肽库进行筛选,3轮亲和筛选后,特异性噬菌体得到了有效富集;对随机挑选的47个噬菌体克隆用ELISA进行鉴定,其中40个为阳性;对40个阳性克隆测序得到3种不同氨基酸序列;用Western blotting对获得的3个不同序列的噬菌体克隆进行抗原性分析,显示这3种噬菌体插入短肽能和H1N1猪流感病毒感染小鼠血清特异性结合。结果表明,本试验获得了3种H1N1猪流感病毒血凝素蛋白模拟抗原表位,它们都具有明显的抗原性,为H1N1猪流感病毒的疫苗研究和诊断奠定了基础。 相似文献
9.
为了对异源抗体对接方法预测流感病毒血凝素B细胞构象表位的可行性进行分析,本研究基于蛋白质相互作用界面的形状互补理论,使用异源抗体(来自于抗原抗体复合物1G9M、1RVF、1TPX、1NCA、1A2Y)的晶体结构同流感病毒血凝素(A/Aichi/2/68(H3N2))的晶体结构进行刚性分子对接,通过计算B细胞表位的预测表面和实际表面C-α原子之间的RSMD以及表位氨基酸的准确率,分析用异源抗体探测出血凝素B细胞表位的可能性。结果表明,不同的异源抗体均可结合到A/Aichi/2/68(H3N2)的已知B细胞表位,最佳的对接构象与原晶体结构重叠后表位残基C-α原子的均方根偏差均小于0.6埃,表位氨基酸预测的准确性大于60%,说明异源抗体对接方法可以尝试用于B细胞构象表位的预测。 相似文献
10.
11.
为对禽流感病毒(AIV)M1蛋白表(拟)位进行分析,本研究采用针对AIV M1蛋白的型特异性单克隆抗体(MAb),淘选M13噬菌体展示的7肽随机肽库,进行M1蛋白表(拟)位分析。筛选获得共有序列MDRxL或HPR,定位于M1蛋白93~99位(93MDRAVKL99)和222~230位(222HPNSSAGLR230)氨基酸区域。采用ELISA、竞争性ELISA分析不同噬菌体拟位与抗M1的MAb免疫反应性,表明含有MDRxL或HPR基序的噬菌体拟位能够与MAb发生特异性结合,并且其结合能够被天然病毒抗原抑制或阻断,表明拟位多肽真实模拟病毒蛋白上与MAb结合的抗原决定簇或表位,提示M1蛋白93~99位(93MDRAVKL99)和222~230位(222HPNSSAGLR230)氨基酸区域构成AIV型特异性表位。 相似文献
12.
XUE Fei YANG Zichun XU Yanhui WANG Yaling YU Ting FAN Maodi LIU Juanhua GAO Song LIU Xiufan 《畜牧兽医学报》1956,51(12):3122-3132
To development monoclonal antibodies against cOmpT of avian pathogenic Escherichia coli (APEC), the recombinant cOmpT of APEC origin expression plasmid pET-28a-compT was employed, and cOmpT protein with a molecular weight about 36 kD in the form of inclusion bodies was obtained after induction with IPTG, and then renatured by urea gradient dialysis. BALB/c mice were immunized with the purified cOmpT. An indirect enzyme-linked immunosorbent assay (iELISA) was developed, the optimal coating concentration of the antigen was 0.625 μg·mL-1 and the optimal serum dilution was 1:6 400. After the fourth immunization, the spleen of immunized mice was collected for cell fusion, three monoclonal hybridomas that can secrete antibody specific to cOmpT were obtained after multiple screenings, named 1G8, 2C3 and 2G3 respectively. And all of their immunoglobulin subclasses were IgG2b. The titers of monoclonal antibodies in the cell culture supernatant were 1:200, 1:3 200 and 1:3 200 determined by iELISA, respectively. All three monoclonal antibodies were confirmed to react with cOmpT in Western blot, without cross reaction with other tested bacteria. The antigenic epitopes recognized by the three monoclonal antibodies were identified by using a series of E. coli strains harboring expression plasmids recombined with truncated fragments from compT gene. The results revealed that the antigenic epitope required for reactivity with the 1G8 was 83DQDWMDS89, and 90SNPGTW95, 197TFKYSGW203were recognized by 2C3 and 2G3, respectively. In this study, three monoclonal antibodies against cOmpT were successfully developed and the antigenic epitopes recognized by the antibodies were identified. The cOmpT specific monoclonal antibodies obtained in this study are potentially useful tools for both the functional study of cOmpT and the development of APEC epitope vaccines. 相似文献
13.
旨在制备禽致病性大肠杆菌(APEC)染色体编码外膜蛋白(cOmpT)的特异性单克隆抗体,本研究利用实验室已构建的APEC cOmpT重组表达质粒pET-28a-compT,经IPTG诱导表达后,获得以包涵体形式存在的约36 ku的重组蛋白cOmpT,利用尿素浓度梯度透析复性获得纯化蛋白cOmpT,并以此免疫BALB/c小鼠。建立间接ELISA检测方法,最适抗原包被浓度为0.625 μg·mL-1,最适血清稀释度为1:6 400。4次免疫后取小鼠脾进行细胞融合,采用有限稀释法多轮筛选后得到3株能稳定分泌针对cOmpT蛋白的单克隆抗体,分别命名为1G8、2C3和2G3,均为IgG2b亚类。3株杂交瘤细胞上清ELISA抗体效价分别为1:200、1:3 200和1:3 200。Western blot结果显示,3株单抗均能与cOmpT发生特异性反应,而不与其他受检菌发生交叉反应。运用原核表达系统对compT基因进行截短表达,对单克隆抗体针对的cOmpT抗原表位进行鉴定,结果显示单抗1G8、2C3和2G3识别的抗原表位分别是83DQDWMDS89、90SNPGTW95和197TFKYSGW203。本研究成功制备了3株抗cOmpT蛋白的单克隆抗体,并对其识别的抗原表位进行了鉴定,为cOmpT蛋白功能研究和APEC新型表位疫苗研发奠定了基础。 相似文献
14.
本试验利用生物软件对H5亚型禽流感病毒A/CK/GD/178/04的血凝素进行抗原特性分析,结合关于禽流感病毒血凝素抗原位点的文献报道,选定97~212位氨基酸和369~529位氨基酸两个区域作为多肽表位候选区域.利用本实验室自主研发的原核表达载体pBT载体,串联表达HA的两个区域,经SDS-PAGE和Western Blotting分析,证明重组产物得到表达,Ni2+柱纯化重组蛋白后,对2周龄SPF鸡进行免疫,经HI试验检测该重组蛋白可以刺激机体产生HI抗体.本研究为H5亚型AIV多肽疫苗的进一步研制奠定了基础. 相似文献
15.
试验旨在应用生物信息学技术综合分析马疱疹病毒1型(equine herpesvirus 1,EHV-1) gB糖蛋白,预测B细胞表位,筛选出具有潜在诊断价值的线性B细胞表位。将EHV-1 gB糖蛋白的基因序列输入DNAStar软件中的Protean工作区中,经参数综合比较分析筛选潜在的B细胞表位,克隆、表达预测表位的基因片段,利用表达的融合蛋白作为抗原与马疱疹病毒阳性血清反应。经预测分析,gB糖蛋白的B细胞表位可能位于第6-10、23-32、53-65、72-98、111-120、152-166和173-180位氨基酸区域。本试验成功构建并原核表达含7个潜在B细胞表位的融合蛋白。Western blotting试验结果显示,其中5个融合蛋白能被马疱疹病毒阳性血清识别。本试验利用生物信息学技术结合分子生物学技术成功筛选到5个潜在的B细胞表位,为EHV-1表位诊断、表位疫苗抗原的设计奠定了技术基础。 相似文献
16.
乙型脑炎病毒E蛋白抗原表位多肽序列鉴定及分析 总被引:1,自引:0,他引:1
为了对流行性乙型脑炎病毒(JEV)E蛋白抗原表位E19进行核心序列定位,本研究设计了一系列编码相互部分重叠短肽核苷酸序列,原核融合表达后经western blot分析,确定其抗原表位核心序列为150ENHGNYS156.该表位在乙型脑炎不同基因型的各种病毒株间为高度保守序列;根据JEV E19表位与同一血清群其他黄病毒之间的差异,在同源序列位置设计了系列突变短肽,融合表达后western blot分析的结果表明,其他黄病毒属病毒同源序列不能与抗JEV阳性血清反应.本实验结果表明JEV E蛋白抗原表位E19具有鉴别检测JEV与西尼罗病毒等其它黄病毒的意义.本实验为进一步研究E蛋白结构和功能以及建立乙型脑炎临床鉴别诊断方法奠定了分子生物学基础. 相似文献
17.
To examine the specificity of the antibody response to the influenza hemagglutinin and the generation of antigenic variants, chickens were immunized against the highly virulent H5 virus A/Ty/Ont/7732/66 (H5N9) and then challenged with a lethal dose of the virus. The antibody responses of these chickens to the hemagglutinin (HA) were examined with an enzyme-linked immunosorbent assay (ELISA) in which their sera were titrated for the ability to block the binding of monoclonal antibodies (MAbs) to five distinct neutralizing epitopes on the viral HA. Based on the ELISA results, a majority (5/6) of the chickens produced antibodies to three of the five neutralizing epitopes on the viral HA. After challenge, two of six immunized chickens shed virus and died; antigenic comparisons of isolates from these two chickens indicated the presence of an antigenic variant; i.e., there was a change in one neutralizing epitope on the HA of virus shed by one chicken. None of the chickens had produced antibodies to this particular epitope on the viral HA. Inoculation of chickens with this variant resulted in 100% mortality, demonstrating that a change in this particular epitope did not alter the virulence of the virus. These studies indicate that chickens immunized against highly virulent influenza viruses may excrete virulent variants following challenge with live virus. 相似文献
18.
利用噬菌体随机12肽库对抗猪瘟病毒(classical swine fever virus CSFV)糖蛋白E2特异的单抗A11进行表位鉴定,经过4轮筛选后,随机挑取10个噬菌体克隆作竞争ELISA检测。结果表明,10个克隆中除4号克隆外,其余9个均能抑制原核表达的E2蛋白和A1l单抗之间的抗原抗体反应,抑制率在35%~64%;DNA测序表明,所有产生竞争抑制作用的8个噬菌体克隆的12肽序列均舍有XXWRXXXL核心序列,而没有抑制作用的克隆则不含该核心序列;Western-blot试验证明,所挑阳性克隆均能被单抗A11识别。多序列比较发现,该核心序列与猪瘟病毒E蛋白的28~35位氨基酸TTWKEYSH有一定的同源性,人工合成的含有部分核心序列氨基酸的多肽可以与单抗A11反应,表明单抗A11所针对的抗原表位位于CSFVE2蛋白的28~35位氨基酸。 相似文献
19.
LI Jing LIU Jian-hua FU Qiang SONG Huan-tang FAN Bin HU Yue RAN Duo-liang 《中国畜牧兽医》2017,44(5):1484-1490
The study was aimed to predict B cell epitopes in gB glycoprotein of equine herpesvirus type 1 (EHV-1) with bioinformatics, and select epitopes which had potential diagnostic value. The DNA fragments of gB glycoprotein were predicted by protean of DNAStar software. Screening potential B cell epitopes after parameter comparison, the target B cell epitopes were selected, cloned and expressed. The expressed fusion proteins serviced as an antigen were used to react with equine herpesvirus positive serum to screen and identify antigenic epitopes. The results showed that according to predictive and analysis, the areas of amino acid from 6 to 10, 23 to 32, 53 to 65, 72 to 98, 111 to 120, 152 to 166, 173 to 180 might be gB glycoprotein B cell epitopes. Seven epitopes were successfully cloned into a prokaryotic expression vector, and confirmed by DNA sequencing. After expression and purification, Western blotting was performed to detect the antigen, which could be recognized by equine herpesvirus positive sera. Bioinformatics technology and molecular biology techniques were used to successfully screen five potential B cell epitopes, which provided the foundation for the diagnosis of EHV-1 and design of the epitope vaccine. 相似文献